Diagnosis of lung cancer using salivary miRNAs expression and clinical characteristics
Abstract Objective Lung cancer (LC), the primary cause for cancer-related death globally is a diverse illness with various characteristics. Saliva is a readily available biofluid and a rich source of miRNA. It can be collected non-invasively as well as transported and stored easily. The process is a...
Saved in:
Main Authors: | Negar Alizadeh, Hoda Zahedi, Maryam Koopaie, Mahnaz Fatahzadeh, Reza Mousavi, Sajad Kolahdooz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-025-03502-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNA155 in non-small cell lung cancer: a potential therapeutic target
by: Xiangju Wei, et al.
Published: (2025-02-01) -
Screening and validation of tsRNAs associated with lung adenocarcinoma
by: LU Chunli, et al.
Published: (2025-01-01) -
Differentially expressed microRNAs in pre-transplant lung biopsies target immune checkpoint proteins and can predict primary graft dysfunction in lung transplantation
by: Vitale Miceli, et al.
Published: (2025-02-01) -
Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs
by: Wei Li, et al.
Published: (2025-02-01) -
MicroRNA-150-3p enhances the antitumour effects of CGP57380 and is associated with a favourable prognosis in non-small cell lung cancer
by: Hongmei Zheng, et al.
Published: (2025-01-01)